#Cancer Research Breast Cancer

The way we screen for breast cancer might be about to change—and it’s a game-changer for saving lives and reducing unnecessary treatments. Take a listen my conversation with Dr. Laura Esserman from @UCSF Breast Care Center @ucsfhealth. She says there is a a smarter, tailor-made approach to breast cancer prevention! She says Research shows that genetic testing and risk models can identify high-risk women early, allowing us to do less for low-risk and more for high-risk groups. Dr. Esserman says It’s about smarter resource use, better outcomes, and less stress for everyone. Are you open to a future where your medical care is personalized based on your unique risk? Think about it—what could this mean for you or your loved ones. This is not a medical podcast. The host, Carl Leibowitz, is not a medical doctor. We conduct conversations with people who are top professionals in their fields and although Dr. Esserman is a medical doctor and a top professional in her field, the views expressed are her own opinion. A Conversation with Carl or Giant Apple Media, LLC does endorse a specific type of treatment or testing timeline for any medical condition. You should always consult your own doctor(s) before making medical decisions about your own or someone’s else’s health. Link for full conversation is in BIO. Like, subscribe and follow for more conversations. #BreastCancer #PersonalizedMedicine #RiskAssessment #HealthInnovation #SaveMoreLives

A new liquid biopsy test analysing circulating tumour DNA (ctDNA) can indicate whether advanced breast cancer patients are likely to respond to specific therapies early in their treatment course. Lower ctDNA levels at the start or after one cycle correlated with longer progression‑free survival, suggesting that this approach could help tailor care and avoid ineffective treatments sooner. https://www.theguardian.com/science/2026/jan/18/simple-blood-test-can-predict-which-breast-cancer-treatment-will-work-best-study-finds?_bhlid=3bf4f6af003e44f570348b7f58797bc43d173b3b #WomensHealth #BreastCancer #PrecisionMedicine #ClinicalInnovation #EvidenceBased

Breast cancer survival shouldn’t be dictated by race, income, or zip code. BCRF investigator Dr. Lisa Newman explains how BCRF investigators are confronting disparities through research into biology, genetics, access, environment, and social determinants of health. This is what real health equity looks like. Comment “MORE” to learn how BCRF is driving this change.

When people think of breast cancer research, they often think of one goal: a cure. But research also improves how we diagnose, treat and support people at every stage of their journey. 🩷 🔬 Research shapes better conversations, more personalised treatment plans, and more informed decisions. #breastcancer #health #cancerreseach

If you have a history of breast cancer and a mutation in an inherited breast cancer gene (i.e., BRCA1/2, PALB2, ATM, or CHEK2), you may be eligible to contribute to tumor genomics studies that are being conducted through the Inherited Cancer Registry (ICARE). Through this effort, we are researching: - breast cancer characteristics - factors associated with outcomes, including treatments - studying genomics of the tumors to better understand pathways to tumor development, which can hopefully lead to new or refined treatment strategies To learn more about participating in ICARE or if you'd like to enroll online, please visit the link in our bio. Once you are enrolled into ICARE, our research team will assess your eligibility for this and other focused research efforts. #ICARE #InheritedCancerRegistry #InheritedCancer #HereditaryCancer #Cancer #BreastCancer #HBOC #BRCA #BRCA1 #BRCA2 #PALB2 #ATM #CHEK2 #CancerGenetics #GeneticTesting #Genomics #TumorTesting #CancerRisks #CancerRiskManagement #CancerPrevention #CancerResearch #CancerTreatment

Can ductal carcinoma in situ (DCIS) be treated non-surgically? Nanotechnology may provide an answer. Scientists are studying localized, non-invasive therapies that deliver treatment directly where it’s needed. Nanotechnology-based drug delivery targeting the breast ducts aims to revolutionize local treatment and prevention of breast cancer. This strategy could one day reduce the need for surgery while improving early intervention and prevention. Learn more: link in bio! #CancerPreventionMonth #CancerResearch #Nanotechnology #BreastHealth #EarlyDetection #MedicalInnovation #HealthAwareness #PreventionIsPower #WomensHealth #BreastCancer

🎥 Now Live – Part 2 of Our STEP Video on Fertility and Breast Cancer We’re pleased to share the second installment of our STEP video series featuring Avner Hershlag, MD, FACOG. Dr. Hershlag, of the Renaissance School of Medicine at Stony Brook University and Island Fertility, discusses how genetics can influence breast cancer risk, including BRCA gene mutations, and how advances in reproductive medicine are helping patients plan for their future families. He also addresses an important question many patients have after diagnosis: Is it safe to become pregnant after breast cancer? Research continues to provide reassuring evidence that pregnancy after treatment does not increase recurrence or reduce survival rates. We are grateful to Dr. Hershlag for sharing his expertise and helping educate patients, caregivers, and families about fertility preservation and family-building after breast cancer. #BreastCancerSupport #FertilityPreservation #Oncofertility #WomensHealth #CancerCare #BreastCancerAwareness #AdelphiBreastCancerProgram

We asked Dr.Norton where he sees the greatest scientific opportunities ahead. This was his answer.

Breast cancer clinical trials shouldn’t be so hard to find and figure out. When I went through my own diagnosis, I was not educated or empowered to understand that clinical trials could be an option for me — or that sometimes you may be able to access tomorrow’s drug today as part of a carefully monitored study.Knowing how hard this journey already is, I created this in a patient‑friendly format that’s easier to navigate and understand, featuring breast cancer clinical trials from BreastCancerTrials.org that are updated in real time so you’re seeing the most current and active options. These include treatment trials (chemotherapy, hormone therapy, radiation, surgery, targeted therapies, PARP and CDK inhibitors, vaccines, immunotherapy), non‑treatment trials (side‑effects, quality of life, imaging, diagnosis, decision support, prevention), and special focus areas like DCIS (including the RECAST trial), genetic testing, fertility, BRCA, brain metastases, and more.If you’re trying to understand what’s possible now — and what might be coming next — this was created to help make those options clearer and easier to navigate.🔗 Link in bio #stage4breastcancer #metastaticbreastcancer #triplenegativebreastcancer #learnlooklocate #clinicaltrials Tag someone who may need this.

HER2+ Breast Cancer: The Most Transformed Disease in Oncology? Few cancer subtypes have evolved as dramatically as HER2-positive breast cancer. In this clip Drs. Alison Conlin & Heather McArthur reflects on decades of progress — from early trastuzumab data to today’s antibody-drug conjugates — and why innovation in this space continues to reshape what cure looks like. #HER2Positive #BreastCancer #Oncology #CancerInnovation #TargetedTherapy Share this with your colleagues and let us know your thoughts in the comments! Be sure to like follow, share, comment, and turn notifications on to be the first to see new clips! You can also click the link in our bio to visit our website or subscribe to Youtube channel to see the full video!

What if there were a way to prevent breast cancer? It may be closer than you think. I spoke with a patient from North Carolina who traveled to the Cleveland Clinic in Ohio to take part in a groundbreaking study. Chase Johnson had triple-negative breast cancer, an aggressive subtype with a recurrence rate as high as 75%. That is a big reason why it can be so deadly. The Cleveland Clinic and Anixa Biosciences are studying a series of shots designed to help prevent the cancer from coming back. Chase says it has been nearly five years, and her cancer has not returned, a milestone researchers have been hoping to see, since recurrence often happens within the first two years. Watch my story at 4 p.m. and 10 p.m., and stay tuned for the full podcast episode featuring both the doctor and the patient. @foxcarolinanews

🎀 Early Detection Saves Lives 🎀 Breast cancer is not just a disease—it’s a battle fought by millions of strong, resilient individuals every day. Awareness, regular self-exams, and timely screenings can make all the difference. ✨ Check yourself. ✨ Support each other. ✨ Speak up and spread awareness. Together, we can fight, support, and win against breast cancer. 💗 #thescitechclub #breastcancerawareness🎀 #sciencefacts #viral #healthcare